title: Expanding access to intravenous tissue-type plasminogen activator treatment with a practice-based telestroke system.
abstract: Emergency stroke treatment would benefit from the increased use of thrombolysis via academic or practice-based telemedicine systems. However, a comparative analysis of these systems has not been undertaken. Data on stroke severity and outcomes after thrombolysis were gathered on patients treated by a practice-based system and compared to published data from academic systems. Patient demographics and outcome measures were not significantly different for patients treated by practice-based or academic providers with the exceptions of lower age and shorter duration of stay in the practice-based treatment group. This study shows that emergency stroke care provided by academic and practice-based telemedicine systems can achieve similar outcomes.
authors.affiliation: AcuteCare Telemedicine, Atlanta, Georgia. Electronic address: keith.sanders@acutecaretelemed.com.
authors.forename: Keith A
authors.initials: KA
authors.lastname: Sanders
authors.forename: Christine
authors.initials: C
authors.lastname: Figiel
authors.forename: James M
authors.initials: JM
authors.lastname: Kiely
authors.forename: Matthews W
authors.initials: MW
authors.lastname: Gwynn
authors.forename: Lisa H
authors.initials: LH
authors.lastname: Johnston
mesh_terms: D000046:Academic Medical Centers; D061605:Administration, Intravenous; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D004185:Disability Evaluation; D004632:Emergency Medical Services; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006297:Health Services Accessibility; D017052:Hospital Mortality; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D019114:Remote Consultation; D012720:Severity of Illness Index; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D017216:Telemedicine; D015912:Thrombolytic Therapy; D013997:Time Factors; D061665:Time-to-Treatment; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
keywords: Tissue-type plasminogen activator; stroke mimic; telemedicine; telestroke; thrombolysis